Suppression of Type I Interferon Signaling in Myeloid Cells by Autoantibodies in Severe COVID-19 Patients
2024 · Journal of Clinical Immunology · 9 citations
https://doi.org/10.1007/s10875-024-01708-7
A
Atsushi Onodera
Chiba University(JP)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
204
Papers
3.9K
Citations
26
h-index
51
i10-index
Atsushi Onodera is an academic researcher from Chiba University. The author has contributed to research in topics: Immune Cell Function and Interaction & Cancer Immunotherapy and Biomarkers & CAR-T cell therapy research. The author has an h-index of 26, co-authored 174 publications.
ORCID: 0000-0002-3715-9408Papers by this author
worksNew Models for Therapeutic Innovation from Japan
2017 · EBioMedicine · 8 citations
https://doi.org/10.1016/j.ebiom.2017.03.042
p53-inducible lncRNA LOC644656 causes genotoxic stress-induced stem cell maldifferentiation and cancer chemoresistance
2025 · Nature Communications · 2 citations
https://doi.org/10.1038/s41467-025-59886-w
Robotically assisted total gastrectomy for lymphadenopathy after long-term follow-up for multiple type 1 gastric neuroendocrine tumor (NET): a case report
2023 · Surgical Case Reports · 1 citations
https://doi.org/10.1186/s40792-023-01725-5
The effects of GATA3 knockdown on the gene expression of Th2-1<sup>st</sup>, Th2-4<sup>th</sup> and memory Th2 cells.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0066468.g006
FIGURE 3 from Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent Manner
2024 · 0 citations
https://doi.org/10.1158/2767-9764.25245030.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat